EXLS · ExlService Holdings, Inc.

The thesis

ExlService Holdings' data-and-AI revenue has lifted its 2026 organic growth guide to 15% and its shares to a 52-week-high close of $43.61 on 5 November 2026. Fourth-quarter results, expected around February 2027, settle whether that pace holds as acquisitions add to reported growth.

The market has answered the question left open by the 27 October 2026 report. The shares closed at $40.93 before that release and now sit above the prior 52-week high of $43.38 (adjusted daily closes).

The narrative is still accelerating: Needham, TD Cowen and Stifel raised their targets on 28 October 2026 and 29 October 2026, and the Aimpoint Digital purchase added fresh news on 5 November 2026. A cut to the 15% organic guide would show this view is wrong.

Bullish and bearish views on ExlService Holdings, Inc.

The bull case on ExlService Holdings, Inc. (EXLS), in brief: Guidance rose a second time. The bear case: Margins are not expanding.

Bull case

• Guidance rose a second time. The 27 October 2026 release lifted 2026 revenue guidance to $2.430–2.440 billion from $2.390–2.415 billion. Adjusted EPS guidance rose to $2.34–2.36 from $2.25–2.29.
• Data-and-AI revenue is carrying growth. It grew 36% reported and 31% organically in the third quarter and was about two-thirds of revenue, management said on the 28 October 2026 call. The second-quarter 10-Q had shown roughly 30% growth.
• Revenue is outrunning hiring. Organic headcount grew 11% against 17% organic revenue growth in the third quarter (28 October 2026 call). About 75% of the business is recurring or annuity-based, and CEO Rohit Kapoor called visibility into next year "as strong as it was last year."
• Aimpoint Digital adds scarce talent. EXL said on 5 November 2026 that it had bought the data and AI consulting firm, adding about 250 specialists and partner work with Anthropic, Databricks and Snowflake. EXL said demand for these engagements is outpacing available talent.
• Analyst targets moved above the price. Needham's target is $50 (Buy, 28 October 2026), TD Cowen's is $49 (Buy, 29 October 2026), Stifel's is $48 (Buy, 29 October 2026) and BofA Securities' is $47 (28 October 2026), per Benzinga.
• The Insurance succession is settled. Management said on 28 October 2026 that Bhupender Singh, president of International Growth Markets, now also leads Insurance after Vivek Jetley's 26 October 2026 departure. Raghav Jaggi leads US Insurance and reports to Singh.

Bear case

• Margins are not expanding. Adjusted operating margin was 19.3% in the third quarter versus 19.4% a year earlier. Management guided full-year margin "fairly flat" on 28 October 2026 and plans to keep investing in technology, AI and infrastructure.
• Deals add growth of unknown size. iMerit, a deal worth up to $310 million that completed on 3 August 2026, contributed $15.3 million of third-quarter revenue. Aimpoint's terms are undisclosed, and the 5 November 2026 release gives no effect on the outlook.
• The legacy book shrank slightly faster. Digital-operations revenue fell 1.7% in the third quarter (28 October 2026 call), after a 1.5% decline in the second. Management calls the decline "by design" as AI-enabled work moves into the data-and-AI category.
• Insurance lagged the group. Insurance grew about 15.5% in the third quarter against 17% for the company on an organic constant-currency measure (28 October 2026 call). That unit now shares a leader with International Growth Markets.
• Crowding signs are visible. The 14-day relative strength index (RSI, a 0–100 gauge of recent buying strength) was 72.1 on 5 November 2026 at a 52-week-high close. StockTitan's filing list shows a Form 144, a notice of a proposed insider sale, on 2 November 2026 and a Form 4 on 3 November 2026; the list names neither filer nor size.
• AI costs may turn volatile. Kapoor said on 28 October 2026 that per-token costs are falling while guardrail and assurance costs are rising, and he expects "a period of volatility" in the cost base.

Price setup

The shares closed at $43.61 on 5 November 2026, which is also the 52-week high, and have gained 24.4% over three months (adjusted daily closes). The climb runs from a $36.48 close on 1 October 2026 through the $40.93 close on 27 October 2026.

RSI was 72.1 on 5 November 2026, down from 78.1 on 27 October 2026 even with the higher price. A close back below $40.93 would erase the entire gain since the third-quarter report. The last close sits below all four broker targets raised or reset after the report, which range from $47 to $50.

Catalysts, next 30 days

• No dated company event through 6 December 2026. Company news through 5 November 2026 shows none, so analyst revisions after the Aimpoint deal and insider filings are the likely news until the next report.
• ~24 February 2027, est.: fourth-quarter 2026 results and first 2027 guidance. The company has not announced the date. This report settles whether growth held and what the 2027 organic guide looks like.
• ~1 March 2027, est.: Form 10-K. The annual filing should show what the company paid for Aimpoint Digital, which the 5 November 2026 release left undisclosed.

What would change the view

A cut to the 15% organic constant-currency growth guide would break the operating case. So would data-and-AI growth falling well short of the 31% organic rate of the third quarter, or digital-operations decline widening beyond 1.7% without data-and-AI growth covering it.

Adjusted operating margin below 19.3% in the fourth quarter would weaken the earnings side of the case. A new deal larger than iMerit, or a gap between reported and organic growth wider than the current 1 to 2 points in the 2027 guide, would show acquisitions doing more of the work.

On price, a daily close below $36 would end the thesis. That level sits under the $36.48 close of 1 October 2026, from which the shares ran to the 52-week high.

What it trades with

• Currency feeds reported results. Delivery is India-weighted, so the US dollar–Indian rupee rate affects reported growth and margin. Third-quarter revenue growth of 19.7% reported compares with 17% at organic constant currency, a gap that includes iMerit's $15.3 million (28 October 2026 call).
• Enterprise AI spending links the shares to partners. The 5 November 2026 Aimpoint deal ties more of the services book to projects built on Anthropic, Databricks and Snowflake. Weak enterprise AI budgets at those partners would likely reach EXL's data-and-AI growth; continued growth near the 31% organic rate of the third quarter would argue against that link mattering.
• Balance sheet leaves room for deals. The company had $333 million in cash and short-term investments against $513 million of debt in the third quarter, with total debt capacity of $1 billion, and repurchased $205 million of stock, about 6.6 million shares, over the first nine months (28 October 2026 call). Interest rates therefore matter more if further deals draw on that capacity.